GETINGE AB Company Getinge AB Deutsche Boerse AG
Equities
GTN
SE0000202624
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.39 EUR | -9.18% |
|
-8.14% | -9.61% |
| 02:45pm | Getinge Shares Sink After It Limits Sales of Heart Devices | DJ |
| 08:35am | Getinge limits sale of heart devices in the US after FDA warning | RE |
Business Summary
- medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.;
- hospital sterilization equipment (29.4%);
- contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications.
Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%).
At the end of 2021, the group had 20 production sites worldwide.
Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).
Number of employees: 11,862
Sales per Business
| SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Acute Care Therapies
51.9
%
| 15,285 | 54.0 % | 16,529 | 51.9 % | +8.14% |
Surgical Workflows
34.5
%
| 8,981 | 31.7 % | 10,974 | 34.5 % | +22.19% |
Life Science
13.6
%
| 4,026 | 14.2 % | 4,325 | 13.6 % | +7.43% |
Sales per region
| SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
36.8
%
| 10,143 | 35.9 % | 11,697 | 36.8 % | +15.32% |
EMEA
9.5
%
| 2,911 | 10.3 % | 3,036 | 9.5 % | +4.29% |
China
8.9
%
| 2,610 | 9.2 % | 2,836 | 8.9 % | +8.66% |
Germany
5.8
%
| 1,631 | 5.8 % | 1,859 | 5.8 % | +13.98% |
France
4.7
%
| 1,251 | 4.4 % | 1,483 | 4.7 % | +18.55% |
Japan
3.9
%
| 1,254 | 4.4 % | 1,241 | 3.9 % | -1.04% |
United Kingdom
3.5
%
| 949 | 3.4 % | 1,100 | 3.5 % | +15.91% |
APAC
3.3
%
| 816 | 2.9 % | 1,051 | 3.3 % | +28.80% |
Italy
3.1
%
| 849 | 3.0 % | 980 | 3.1 % | +15.43% |
Spain
2.3
%
| 649 | 2.3 % | 738 | 2.3 % | +13.71% |
Canada
2.3
%
| 606 | 2.1 % | 731 | 2.3 % | +20.63% |
Australia
2.0
%
| 582 | 2.1 % | 643 | 2.0 % | +10.48% |
Sweden
2.0
%
| 549 | 1.9 % | 632 | 2.0 % | +15.12% |
Netherlands
1.6
%
| 496 | 1.8 % | 518 | 1.6 % | +4.44% |
India
1.5
%
| 534 | 1.9 % | 491 | 1.5 % | -8.05% |
Switzerland
1.3
%
| 284 | 1.0 % | 423 | 1.3 % | +48.94% |
Americas
1.3
%
| 444 | 1.6 % | 413 | 1.3 % | -6.98% |
Hong Kong
1.2
%
| 354 | 1.3 % | 377 | 1.2 % | +6.50% |
Denmark
1.1
%
| 265 | 0.9 % | 345 | 1.1 % | +30.19% |
Belgium
1.1
%
| 296 | 1.0 % | 342 | 1.1 % | +15.54% |
Brazil
1.0
%
| 274 | 1.0 % | 305 | 1.0 % | +11.31% |
South Korea
1.0
%
| 304 | 1.1 % | 304 | 1.0 % | 0.00% |
Austria
0.9
%
| - | - | 283 | 0.9 % | - |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 17-04-30 | |
Agneta Palmér
DFI | Director of Finance/CFO | - | 22-09-14 |
Johan Malmquist
CHM | Chairman | 63 | 96-12-31 |
Anna Romberg
CMP | Compliance Officer | 45 | 20-09-30 |
| Director/Board Member | 73 | 88-12-31 | |
Lars Mattsson
IRC | Investor Relations Contact | - | 16-08-31 |
Henrik Stenmo
PRN | Corporate Officer/Principal | - | 21-06-29 |
Joanna Engelke
LAW | General Counsel | 64 | 22-10-05 |
Carsten Blecker
PRN | Corporate Officer/Principal | 58 | 13-12-31 |
Magnus Lundbäck
HRO | Human Resources Officer | 55 | 16-12-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Johan Bygge
BRD | Director/Board Member | 68 | 06-12-31 |
| Director/Board Member | 73 | 88-12-31 | |
Johan Malmquist
CHM | Chairman | 63 | 96-12-31 |
| Director/Board Member | 56 | 14-03-19 | |
| Director/Board Member | 61 | 10-04-20 | |
| Chief Executive Officer | 52 | 17-04-30 | |
Barbro Fridén
BRD | Director/Board Member | 68 | 16-12-31 |
Dan Frohm
BRD | Director/Board Member | 43 | 17-02-21 |
Frida Gustafsson
BRD | Director/Board Member | 39 | 21-12-31 |
| Director/Board Member | 48 | 19-12-31 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 10 | 18,217,200 | 0 | 0 | 79.06 % |
| Stock B | 1 | 254,152,373 | 215,331,788 ( 84.73 %) | 0 |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Getinge India Pvt Ltd.
| |
Medical Distributors
| |
MAQUET Medical Systems AG
 MAQUET Medical Systems AG Chemicals: Major DiversifiedProcess Industries Part of Getinge AB, MAQUET Medical Systems AG is a German company that manufactures and distributes medical devices and disinfectants. The private company is based in Rastatt, Germany and was founded in 2014. |
Chemicals: Major Diversified
|
Maquet GmbH (Germany)
| |
Getinge Treasury AB
| |
Getinge Treasury Ireland DAC
|
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
217.1
SEK
Average target price
233.1
SEK
Spread / Average Target
+7.37%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +73.70% | 12.43B | |
| -18.69% | 8.09B | |
| -1.69% | 6.12B | |
| +16.74% | 5.59B | |
| +39.93% | 5.23B | |
| -16.51% | 4.1B | |
| -27.82% | 2.65B | |
| +1.49% | 1.99B | |
| +5.99% | 1.96B |
- Stock Market
- Equities
- GETI B Stock
- GTN Stock
- Company Getinge AB